- Home
- ATHE vs PRPO Comparison
ATHE vs PRPO Comparison
Compare ATHE & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATHE
- PRPO
- Stock Information
- Founded
- ATHE 1997
- PRPO N/A
- Country
- ATHE Australia
- PRPO United States
- Employees
- ATHE N/A
- PRPO N/A
- Industry
- ATHE Biotechnology: Pharmaceutical Preparations
- PRPO Biotechnology: Laboratory Analytical Instruments
- Sector
- ATHE Health Care
- PRPO Industrials
- Exchange
- ATHE Nasdaq
- PRPO Nasdaq
- Market Cap
- ATHE 10.1M
- PRPO 8.8M
- IPO Year
- ATHE N/A
- PRPO N/A
- Fundamental
- Price
- ATHE $2.20
- PRPO $5.27
- Analyst Decision
- ATHE Strong Buy
- PRPO
- Analyst Count
- ATHE 2
- PRPO 0
- Target Price
- ATHE $6.00
- PRPO N/A
- AVG Volume (30 Days)
- ATHE 121.1K
- PRPO 5.8K
- Earning Date
- ATHE 02-15-2025
- PRPO 11-06-2024
- Dividend Yield
- ATHE N/A
- PRPO N/A
- EPS Growth
- ATHE N/A
- PRPO N/A
- EPS
- ATHE N/A
- PRPO N/A
- Revenue
- ATHE $2,681,669.00
- PRPO $17,411,000.00
- Revenue This Year
- ATHE N/A
- PRPO $75.18
- Revenue Next Year
- ATHE N/A
- PRPO N/A
- P/E Ratio
- ATHE N/A
- PRPO N/A
- Revenue Growth
- ATHE 2.63
- PRPO 31.31
- 52 Week Low
- ATHE $1.00
- PRPO $4.31
- 52 Week High
- ATHE $3.19
- PRPO $7.30
- Technical
- Relative Strength Index (RSI)
- ATHE 64.85
- PRPO 32.33
- Support Level
- ATHE $2.04
- PRPO $5.72
- Resistance Level
- ATHE $2.45
- PRPO $6.48
- Average True Range (ATR)
- ATHE 0.23
- PRPO 0.24
- MACD
- ATHE -0.00
- PRPO -0.05
- Stochastic Oscillator
- ATHE 71.15
- PRPO 3.98
About ATHE Alterity Therapeutics Limited
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.